Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roche Holding AG (RHHVF – Research Report) ...
Sana’s HIP technology aims to eliminate the ... In the past 30 days, estimates for CytomX Therapeutics’ 2024 loss per share have remained constant at 5 cents. Estimates for 2025 loss per ...
Pre-earnings options volume in Sana Biotechnology (SANA) is 2.0x normal with calls leading puts 150:1. Implied volatility suggests the market ...
Sana Biotechnology Inc. (SANA ... Short interest is at 16.6%. Silexion Therapeutics Corp. (SLXN) – 92% Jump In Followers Silexion, an oncology-focused biotech developing RNA interference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results